Jesus Hernandez-Monge

Jesus Hernandez-Monge

Auto-generated profile, based on publicly available information

Jesus Hernandez-Monge

Investigador por México SECIHTI- Instituto de Física, Universidad Autónoma de San Luis Potosí, Mexico

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2020 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
JHJesus Hernandez-Monge
Jesus Hernandez-Monge
Mayra Martinez SanchezMayra Martinez Sanchez
Mayra Martinez Sanchez
ARAdriana Rousset-Roman
Adriana Rousset-Roman
IMIxaura Medina-Medina
Ixaura Medina-Medina
Vanesa Olivares-IllanaVanesa Olivares-Illana
Vanesa Olivares-Illana

22 April 2026 in The Journal of Liquid Biopsy
Verified
Journal Article
Open access
ARAndrés Rodríguez-Rodríguez
Andrés Rodríguez-Rodríguez
KCKarla Grisel Calderón-González
Karla Grisel Calderón-González
JLJuan Pedro Luna-Arias
Juan Pedro Luna-Arias
MMMariana Moctezuma-Dávila
Mariana Moctezuma-Dávila
MRMartha Rangel-Charqueño
Martha Rangel-Charqueño
JHJesús Hernández-Monge
Jesús Hernández-Monge
The most common ocular neoplasia among children is retinoblastoma. Currently, the diagnosis of this disease is essentially clinical, taking a biopsy is contraindicated owing to the high risk of causing metastasis. Therefore, it is imperative the development of a method to diagnose this disease through a non-invasive fashion. We choose tears as they fulfill the former precept. Through proteomic analysis we observed 52 up regulated and 48 down regulated proteins among retinoblastoma cases as compared to healthy children. Among these proteins, we identified several previously associated with retinoblastoma such as apolipoprotein A-1 (APOA1). We confirmed up regulation of APOA1 and S100 binding calcium A9 (S100A9) which revealed faithful concordance to the predicted values from mass spectrometry.